In the United States and around the globe, May 16 is recognized as Celiac Awareness Day, and Beyond Celiac has joined the #ShineALightOnCeliac campaign to help spread awareness. As part of the campaign, several organizations including Coeliac Australia, Canadian Celiac Association, Coeliaque Québec, Coelicak UK, and Celíacos do Brasil agreed to light up world landmarks in green to raise awareness about gluten-free food insecurity, the need for research, and other celiac disease-related issues.
Author: Abhay Panchal
Michelle Kang Kim, MD, PhD, the chair of the Department of Gastroenterology, Hepatology and Nutrition at Cleveland Clinic, in Cleveland, talks about breaking the glass ceiling, sharing insights into the process of becoming a leader. Dr. Kim told Gastroenterology & Endoscopy News at Digestive Disease Week 2023 that the path to becoming a chair is not always intuitive.- GEN Staff
DUBLIN — A swallowable gastric balloon (Allurion Balloon, formerly known as Elipse) combined with daily subcutaneous injections of the glucagon-like peptide 1 (GLP-1) agonist liraglutide (Saxenda, Novo Nordisk), leads to a significant average total body weight loss of 19% (18 kg or 40 lb) after around 4 months in people with obesity. “The combination therapy [balloon and liraglutide] resulted in an additional weight loss compared to the two single treatments,” said Roberta Ienca, MD, from the Clinica Nuova Villa Claudia, Rome, Italy, who presented the findings at this year’s European Congress on Obesity (ECO). “Despite both the balloon and liraglutide…
NEWPORT BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, announced a significant advance in the management of irritable bowel syndrome (IBS). The inFoods® IBS diagnostic test has now been validated for use with finger stick (capillary) patient whole blood samples simplifying sample collection and facilitating wider access to the test. With this new finger stick blood collection option, any trained medical professional in the doctor’s office can collect the patient’s blood sample during their office visit and forward the sample to the Lab for processing.…
There are a number of utilities for artificial intelligence (AI) in medicine that could have a drastic impact on the field? One such method is for polyp detection following a colonoscopy for colorectal cancer screenings. In a presentation during the 2023 Digestive Disease Week (DDW) in Chicago, Aasma Shaukat, MD, MPH, Director of Research Outcomes, Division of Gastroenterology and Hepatology, NYU Langone, discussed how doctors can better use new technologies like AI for cancer screenings. “Artificial intelligence is here to stay,” Shaukat said in an interview with HCPLive®. “It will make our job in delivering health care and promoting and…
The American College of Gastroenterology recently released an updated clinical guideline on the diagnosis and management of celiac disease (Am J Gastroenterol 2023;118[1]:59-76). GEN‘s Sarah Tilyou spoke with lead author Alberto Rubio Tapia, MD, the director of the celiac disease program at Cleveland Clinic, in Ohio, about the impetus for the guideline and what it means to GI practice.
As we have previously noted, private equity (PE) firms have been increasingly drawn to the health care sector as a profitable investment opportunity. PE is a type of investment that involves pooling funds from investors in order to acquire companies with a goal of improving their financial performance to then sell them for a profit. One recent area of interest for PE firms has been gastroenterology, the branch of medicine that focuses on the digestive system and its disorders. Private equity firms are attracted to this field due to the steady demand for gastrointestinal (GI) services, which are required by…
Gastroenterology is a service line with unlimited potential for growth. The expanding patient need for services, combined with advancements that allow more procedures to be performed in outpatient settings, have made gastroenterology an attractive target for investors. Patients utilize gastroenterology services throughout their lifetimes. Gastroenterologists treat a wide variety of conditions impacting the digestive system, which includes the stomach, intestines, gallbladder, pancreas, and liver. Clinicians care for patients experiencing everything from abdominal pain and heartburn to nonalcoholic fatty liver disease and cancers. The stats show that chronic digestive issues keep providers busy:
Key takeaways: The FDA has approved AbbVie’s Rinvoq as a once-day pill intended for the treatment of adult patients with moderate to severe Crohn’s disease who are intolerant, or have had an inadequate response, to one or more TNF inhibitors.
New York tops the list of states that are most in-demand for permanent placement opportunities for gastroenterologists, according to a post from physician search and employment firm Merritt Hawkins. Ten most in-demand states for permanent GI placement: